BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28059867)

  • 1. Influence of the KDM4A rs586339 polymorphism on overall survival in Asian non-small-cell lung cancer patients.
    Marvalim C; Wong JX; Sutiman N; Lim WT; Tan SW; Kanesvaran R; Ng QS; Jain A; Ang MK; Tan WL; Toh CK; Tan EH; Chowbay B
    Pharmacogenet Genomics; 2017 Mar; 27(3):120-123. PubMed ID: 28059867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A coding single-nucleotide polymorphism in lysine demethylase KDM4A associates with increased sensitivity to mTOR inhibitors.
    Van Rechem C; Black JC; Greninger P; Zhao Y; Donado C; Burrowes PD; Ladd B; Christiani DC; Benes CH; Whetstine JR
    Cancer Discov; 2015 Mar; 5(3):245-54. PubMed ID: 25564517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A genetic polymorphism in pre-miR-27a confers clinical outcome of non-small cell lung cancer in a Chinese population.
    Xu J; Yin Z; Shen H; Gao W; Qian Y; Pei D; Liu L; Shu Y
    PLoS One; 2013; 8(11):e79135. PubMed ID: 24223174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single nucleotide polymorphisms in VTI1A gene contribute to the susceptibility of Chinese population to non-small cell lung cancer.
    Su WM; Chen ZH; Zhang XC; Su J; Xie Z; Yan HH; Yang JJ; Chen HJ; Zhou Q; Zhong WZ; Guo WB; Chen SL; Wu YL
    Int J Biol Markers; 2015 Jul; 30(3):e286-93. PubMed ID: 25744365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of ERBB4 genetic polymorphism with the risk and prognosis of non-small cell lung cancer in Chinese Han population: A population-based case-control study.
    Wang WP; Bian HB; Wang XZ; Liu L; Wei D
    Medicine (Baltimore); 2021 May; 100(19):e25762. PubMed ID: 34106605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between single nucleotide polymorphisms of the transforming growth factor-β1 gene and overall survival in unresectable locally advanced non-small-cell lung cancer patients treated with radio(chemo)therapy in a Chinese population.
    Xue SL; Zheng YH; Su HF; Deng X; Zhang XB; Zou CL; Hu ML; Xie CY
    Med Oncol; 2013 Jun; 30(2):512. PubMed ID: 23435990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FoxP3 genetic variants and risk of non-small cell lung cancer in the Chinese Han population.
    He YQ; Bo Q; Yong W; Qiu ZX; Li YL; Li WM
    Gene; 2013 Dec; 531(2):422-5. PubMed ID: 24035934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variants in microRNAs predict non-small cell lung cancer prognosis in Chinese female population in a prospective cohort study.
    Lingzi X; Zhihua Y; Xuelian L; Yangwu R; Haibo Z; Yuxia Z; Baosen Z
    Oncotarget; 2016 Dec; 7(50):83101-83114. PubMed ID: 27825117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of the stem cell marker gene
    Liu QF; Zhang ZF; Hou GJ; Yang GY; He Y
    BMJ Open; 2017 Aug; 7(8):e016913. PubMed ID: 28827262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms of EpCAM gene and prognosis for non-small-cell lung cancer in Han Chinese.
    Yang Y; Fei F; Song Y; Li X; Zhang Z; Fei Z; Su H; Wan S
    Cancer Sci; 2014 Jan; 105(1):89-96. PubMed ID: 24304228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of polymorphisms at HORMAD2 and prognosis in advanced non-small-cell lung cancer patients.
    Zhang K; Tang S; Cao S; Hu L; Pan Y; Ma H; Guo X; Wu S; Shen H; Hu Z
    Cancer Epidemiol; 2014 Aug; 38(4):414-8. PubMed ID: 24797335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A potentially functional polymorphism in ABCG2 predicts clinical outcome of non-small cell lung cancer in a Chinese population.
    Sun J; Zhu M; Shen W; Wang C; Dai J; Xu L; Jin G; Hu Z; Ma H; Shen H
    Pharmacogenomics J; 2017 Jun; 17(3):280-285. PubMed ID: 26951883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between polymorphisms in COMT, PLCH1, and CYP17A1, and non-small-cell lung cancer risk in Chinese nonsmokers.
    Zhang Y; Hua S; Zhang A; Kong X; Jiang C; Deng D; Wenlong B
    Clin Lung Cancer; 2013 Jan; 14(1):45-9. PubMed ID: 22658813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case-Control Study on Impact of the Telomerase Reverse Transcriptase Gene Polymorphism and Additional Single Nucleotide Polymorphism (SNP)- SNP Interaction on Non-Small Cell Lung Cancers Risk in Chinese Han Population.
    Xing YL; Liu F; Li JF; Lin JC; Zhu GD; Li M; Zhang CR; Niu YY
    J Clin Lab Anal; 2016 Nov; 30(6):1071-1077. PubMed ID: 27154632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SNP (-617C>A) in ARE-like loci of the NRF2 gene: a new biomarker for prognosis of lung adenocarcinoma in Japanese non-smoking women.
    Okano Y; Nezu U; Enokida Y; Lee MT; Kinoshita H; Lezhava A; Hayashizaki Y; Morita S; Taguri M; Ichikawa Y; Kaneko T; Natsumeda Y; Yokose T; Nakayama H; Miyagi Y; Ishikawa T
    PLoS One; 2013; 8(9):e73794. PubMed ID: 24040073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum.
    Liao WY; Ho CC; Tsai TH; Chen KY; Shih JY; Yu CJ
    Lung Cancer; 2018 Apr; 118():90-96. PubMed ID: 29572009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of TAP polymorphisms with non-small-cell lung cancer in the Han Chinese population.
    Liu W; Ma Q; Li C; Li Y; Liu S; Shi L; Yao Y
    Hum Immunol; 2021 Dec; 82(12):917-922. PubMed ID: 34373132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CC genotype of anti-apoptotic gene BCL-2 (-938 C/A) is an independent prognostic marker of unfavorable clinical outcome in patients with non-small-cell lung cancer.
    Javid J; Mir R; Mirza M; Imtiyaz A; Prasant Y; Mariyam Z; Julka PK; Mohan A; Lone M; Ray PC; Saxena A
    Clin Transl Oncol; 2015 Apr; 17(4):289-95. PubMed ID: 25257838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy.
    Kim SH; Lee GW; Lee MJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Hwang YS; Kim IS; Lee S; Oh SY
    Lung Cancer; 2012 Sep; 77(3):578-84. PubMed ID: 22608006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variants in
    He Y; Wang G; Wang Q; Zhao Z; Gan L; Yang S; Wang Y; Guo S; An J; Zhang J; Zhang Z; Zhou F
    Future Oncol; 2021 Mar; 17(7):795-805. PubMed ID: 33541123
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.